探索在偏头痛中无处不在修饰的作用
Qian Zhu1,2, Jin Yang1,2, Lei Shi1,2
1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Frontiers in immunology
|February 17, 2025
概括
这篇评论探讨了ubiquitination如何调节偏头痛中的关键信号通路,重点关注其在神经炎症和疼痛中的作用. 了解这些机制可能会导致新的偏头痛诊断和治疗.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 偏头痛是一种复杂的神经血管疾病,涉及三角血管系统激活,敏感化和神经炎症.
- 素基因相关 (CGRP) 和像MAPK和NF-κB这样的信号通路是偏头痛病原体的核心.
- 无素-蛋白酶体系统 (UPS) 在神经和炎症条件中起作用.
研究的目的:
- 系统地审查ubiquitination在调节偏头痛中MAPK和NF-κB信号通路中的作用.
- 为了阐明在神经炎症和疼痛信号放大中泛素酶的机制.
- 探索ubiquitination作为偏头痛的诊断和治疗点的潜力.
主要方法:
- 系统性文献综述,重点关注在偏头痛中的无处不在,MAPK,NF-κB,神经炎症和疼痛信号.
- 参与无处不在的酶 (E1,E2,E3) 级联的分析.
- 探索UPS活动与偏头痛病理生理学之间的联系.
主要成果:
- 通过无处不在调节的MAPK和NF-κB通路的异常激活,有助于偏头痛的发作和慢性化.
- 乌比基化酶与神经炎症和 nociceptive信号的放大有关.
- UPS的失调与神经和炎症性疾病有关,包括偏头痛.
结论:
- 在偏头痛的发病过程中,乌比基因是关键信号通路的关键调节者.
- 准无素-蛋白酶体系统为新型诊断生物标志物和偏头痛治疗策略提供了潜力.
- 对无处不在酶的进一步研究可以改善偏头痛管理和疾病慢性监测.
相关概念视频
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
The Proteasome
801
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
801
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Export of Misfolded Proteins out of the ER
3.4K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.4K
Protein Modifications in the RER
5.0K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.0K


